| Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis MC Fargnoli, M Esposito, S Ferrucci, G Girolomoni, A Offidani, A Patrizi, ... Journal of Dermatological Treatment 32 (5), 507-513, 2021 | 80 | 2021 |
| Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study C Patruno, M Napolitano, G Argenziano, K Peris, M Ortoncelli, ... Journal of the European Academy of Dermatology and Venereology 35 (4), 958-964, 2021 | 80 | 2021 |
| An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease M Megna, C Patruno, A Balato, F Rongioletti, L Stingeni, N Balato Archives of dermatological research 309, 443-452, 2017 | 60 | 2017 |
| IL12B (p40) gene polymorphisms contribute to ustekinumab response prediction in psoriasis M Galluzzo, AN Boca, E Botti, C Potenza, G Malara, P Malagoli, S Vesa, ... Dermatology 232 (2), 230-236, 2016 | 59 | 2016 |
| Secukinumab shows high efficacy irrespective of HLA‐Cw6 status in patients with moderate‐to‐severe plaque‐type psoriasis: SUPREME study A Costanzo, L Bianchi, ML Flori, G Malara, L Stingeni, M Bartezaghi, ... British journal of dermatology 179 (5), 1072-1080, 2018 | 57 | 2018 |
| Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study F Sampogna, L Puig, P Spuls, G Girolomoni, MA Radtke, B Kirby, ... British Journal of Dermatology 176 (5), 1195-1203, 2017 | 57 | 2017 |
| Treat-to-target approach for the management of patients with moderate-to-severe plaque psoriasis: consensus recommendations P Gisondi, M Talamonti, A Chiricozzi, S Piaserico, P Amerio, A Balato, ... Dermatology and Therapy 11, 235-252, 2021 | 49 | 2021 |
| Italian guidelines for therapy of atopic dermatitis—Adapted from consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) G Damiani, P Calzavara‐Pinton, L Stingeni, K Hansel, F Cusano, ... Dermatologic Therapy 32 (6), e13121, 2019 | 48 | 2019 |
| Italian expert consensus for the management of actinic keratosis in immunocompetent patients K Peris, PG Calzavara‐Pinton, L Neri, G Girolomoni, G Malara, A Parodi, ... Journal of the European Academy of Dermatology and Venereology 30 (7), 1077-1084, 2016 | 48 | 2016 |
| Photodynamic therapy of acne using methyl aminolaevulinate diluted to 4% together with low doses of red light L Mavilia, G Malara, G Moretti, M Lo Re, AP Guerra British Journal of Dermatology 157 (4), 810-811, 2007 | 48 | 2007 |
| Lymphocutaneous sporotrichosis in an immunocompetent patient: a case report from extreme southern Italy G Criseo, G Malara, O Romeo, A Puglisi Guerra Mycopathologia 166, 159-162, 2008 | 38 | 2008 |
| C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis P Gisondi, M Malerba, G Malara, AP Guerra, R Sala, A Radaeli, ... International journal of immunopathology and pharmacology 23 (4), 1195-1202, 2010 | 37 | 2010 |
| Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience A Conti, F Peccerillo, P Amerio, A Balato, F Bardazzi, L Bianchi, ... British Journal of Dermatology 180 (6), 1547-1548, 2019 | 36 | 2019 |
| Effectiveness end points in real-world studies on biological therapies in psoriasis: systematic review with focus on drug survival A Costanzo, G Malara, C Pelucchi, F Fatiga, G Barbera, A Franchi, ... Dermatology 234 (1-2), 1-12, 2018 | 36 | 2018 |
| HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa K Peris, A Lo Schiavo, G Fabbrocini, V Dini, A Patrizi, M Fusano, L Bianchi, ... Journal of the European Academy of Dermatology and Venereology 33 (4), 766-773, 2019 | 34 | 2019 |
| Consensus on the management of patients with psoriatic arthritis in a dermatology setting P Gisondi, G Altomare, F Ayala, A Conti, P Dapavo, C De Simone, C Foti, ... Journal of the European Academy of Dermatology and Venereology 32 (4), 515-528, 2018 | 33 | 2018 |
| Dupilumab treatment in children aged 6–11 years with atopic dermatitis: a multicentre, real-life study M Napolitano, G Fabbrocini, I Neri, L Stingeni, V Boccaletti, V Piccolo, ... Pediatric Drugs 24 (6), 671-678, 2022 | 30 | 2022 |
| Moderate‐to‐severe atopic dermatitis in adolescents treated with dupilumab: a multicentre Italian real‐world experience L Stingeni, L Bianchi, E Antonelli, ES Caroppo, SM Ferrucci, M Ortoncelli, ... Journal of the European Academy of Dermatology and Venereology 36 (8), 1292-1299, 2022 | 28 | 2022 |
| Secukinumab shows high efficacy irrespective of HLA‐Cw6 status in patients with moderate‐to‐severe plaque‐type psoriasis: results from extension phase of the … M Papini, F Cusano, M Romanelli, M Burlando, G Stinco, G Girolomoni, ... British Journal of Dermatology 181 (2), 413-414, 2019 | 26 | 2019 |
| Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: a 104‐week multicenter retrospective study–IL PSO … L Gargiulo, L Ibba, P Malagoli, RG Angileri, F Bardazzi, N Bernardini, ... Journal of the European Academy of Dermatology and Venereology 37 (5), 1017-1027, 2023 | 21 | 2023 |
Paolo GisondiProfessore associato, Dipartimento di Medicina, Sez. Dermatologia, Università di Verona在 univr.it 的电子邮件经过验证
